As Payments Analyst, you will make sure the people and organisations behind our clinical trials are paid accurately, on time and in line with the rules. You will be the central point for payment requests across the affiliate, keeping every payment visible from request to completion. Your work helps investigators, trial sites and suppliers keep studies moving, so clinical research can progress for people living with serious chronic diseases.
You will be part of the Business Operations team, reporting to the Business Operations Manager. You will work in line with local regional requirements and give global and International Operations support when needed.
You will also work with clinical operations and other cross-functional colleagues, and with Finance, Procurement and shared services. Outside Novo, you will be in contact with investigators and trial site administrative teams, vendors and suppliers, ethics committees, regulatory bodies and, where relevant, insurance providers and brokers.
You will be trusted to own your area and make your voice heard. You will build your skills in clinical trial finance and payment processes, and you will learn from colleagues across clinical and finance teams. You will be encouraged to try digital tools and to improve how payments are done, and your work will be recognised through clear performance expectations.
Your impact begins today. Apply for the Payments Analyst role by 26 November 2026. We review applications as they come in, so we encourage you to apply early.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html